Growth hormone-releasing effect of an enkephalin analog in the dog: evidence for cholinergic mediation.
D000109:Acetylcholine / Q000502:physiology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002086:Butylscopolammonium Bromide / Q000494:pharmacology; D005405:D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; D004285:Dogs; D004723:Endorphins / Q000494:pharmacology*; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D013006:Growth Hormone / Q000097:blood*; D013007:Growth Hormone-Releasing Hormone; D006728:Hormones / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000502:physiology
D004723:Endorphins; D006728:Hormones; D011976:Receptors, Muscarinic; D010868:Pimozide; D002086:Butylscopolammonium Bromide; D009270:Naloxone; D004744:Enkephalin, Methionine; D005405:D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; D001285:Atropine; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D010830:Physostigmine; D000109:Acetylcholine